{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:31:45Z","timestamp":1761129105849},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/01.med.0000436185.36717.76","type":"journal-article","created":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T08:42:58Z","timestamp":1382431378000},"page":"517-522","source":"Crossref","is-referenced-by-count":15,"title":["Male hypogonadism and skeletal health"],"prefix":"10.1097","volume":"20","author":[{"given":"Michael S.","family":"Irwig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20211004","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1210\/jc.2009-2635","article-title":"Osteoporotic Fractures in Men Study (MrOS) Research GroupSex steroid hormones in older men: longitudinal associations with 4.5-year change in hip bone mineral density - the osteoporotic fractures in men study.","volume":"95","author":"Cauley","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R2-4-20211004","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2011-3045","article-title":"Endocrine SocietyOsteoporosis in men: an Endocrine Society clinical practice guideline.","volume":"97","author":"Watts","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-4-20211004","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1210\/jc.2012-1677","article-title":"Cortical consolidation of the radius and tibia in young men and women.","volume":"97","author":"Walsh","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-4-20211004","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1530\/EJE-11-0353","article-title":"EMAS GroupInfluence of bone remodelling rate on quantitative ultrasound parameters at the calcaneus and DXA BMDa of the hip and spine in middle-aged and elderly European men: the European Male Ageing Study (EMAS).","volume":"165","author":"Boonen","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"R5-4-20211004","doi-asserted-by":"crossref","first-page":"E232","DOI":"10.25011\/cim.v34i4.15365","article-title":"Elevated serum receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in late-onset male hypogonadism.","volume":"34","author":"Pepene","year":"2011","journal-title":"Clin Invest Med"},{"key":"R6-4-20211004","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2011-2513","article-title":"EMAS GroupCharacteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS).","volume":"97","author":"Tajar","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-4-20211004","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00198-010-1437-5","article-title":"EMAS study groupInfluence of age and sex steroids on bone density and geometry in middle-aged and elderly European men.","volume":"22","author":"Ward","year":"2011","journal-title":"Osteoporos Int"},{"key":"R8-4-20211004","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2265.2011.04212.x","article-title":"Estradiol levels predict bone mineral density in male collegiate athletes: a pilot study.","volume":"76","author":"Ackerman","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R9-4-20211004","doi-asserted-by":"crossref","first-page":"e11529","DOI":"10.1371\/journal.pone.0011529","article-title":"Bone mass and the CAG and GGN androgen receptor polymorphisms in young men.","volume":"5","author":"Guadalupe-Grau","year":"2010","journal-title":"PLoS One"},{"key":"R10-4-20211004","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1210\/jc.2011-3058","article-title":"Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis.","volume":"97","author":"Drake","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-4-20211004","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1210\/jc.2006-0173","article-title":"Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men.","volume":"91","author":"Fink","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-4-20211004","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00198-011-1552-y","article-title":"Sex steroids and bone health in older Chinese men.","volume":"23","author":"Woo","year":"2012","journal-title":"Osteoporos Int"},{"key":"R13-4-20211004","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.amjmed.2005.10.048","article-title":"Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study.","volume":"119","author":"Amin","year":"2006","journal-title":"Am J Med"},{"key":"R14-4-20211004","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1530\/EJE-11-0808","article-title":"Secular trends in sex hormones and fractures in men and women.","volume":"166","author":"Trimpou","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"R15-4-20211004","doi-asserted-by":"crossref","first-page":"E739","DOI":"10.1210\/jc.2010-1878","article-title":"Bone mass in subjects with Klinefelter syndrome: role of testosterone levels and androgen receptor gene CAG polymorphism.","volume":"96","author":"Ferlin","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-4-20211004","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00198-010-1354-7","article-title":"Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone.","volume":"22","author":"Bojesen","year":"2011","journal-title":"Osteoporos Int"},{"key":"R17-4-20211004","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.juro.2011.03.111","article-title":"Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancer.","volume":"186","author":"Saylor","year":"2011","journal-title":"J Urol"},{"key":"R18-4-20211004","doi-asserted-by":"crossref","first-page":"E456","DOI":"10.1210\/jc.2010-0902","article-title":"Structural decay of bone microarchitecture in men with prostate cancer treated with androgen deprivation therapy.","volume":"95","author":"Hamilton","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-4-20211004","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/j.1464-410X.2010.09726.x","article-title":"Bicalutamide monotherapy preserves bone mineral density, muscle strength and has significant health-related quality of life benefits for osteoporotic men with prostate cancer.","volume":"107","author":"Wadhwa","year":"2011","journal-title":"BJU Int"},{"key":"R20-4-20211004","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(11)61226-9","article-title":"Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.","volume":"379","author":"Smith","year":"2012","journal-title":"Lancet"},{"key":"R22-4-20211004","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1532-5415.2010.02865.x","article-title":"Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty.","volume":"58","author":"Kenny","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"R23-4-20211004","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1056\/NEJMoa1204061","article-title":"Fracture risk and zoledronic acid therapy in men with osteoporosis.","volume":"367","author":"Boonen","year":"2012","journal-title":"N Engl J Med"},{"key":"R24-4-20211004","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1210\/jc.2012-1569","article-title":"A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density.","volume":"97","author":"Orwoll","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Current Opinion in Endocrinology, Diabetes &amp; Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201312000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T07:18:18Z","timestamp":1633504698000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201312000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/01.med.0000436185.36717.76","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}